Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

EyePoint, Inc. Common Stock

EYPT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of EYPT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
EYPT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
EYPT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
EYPT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in EYPT holdings by institutional investors

Quarterly net insider trading by EYPT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $80,000 Jan 15, 2023 Issue: Medicare/Medicaid Health Issues
  • $80,000 Oct 17, 2022 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jul 16, 2022 Issue: Medicare/Medicaid Health Issues
  • $80,000 Apr 15, 2022 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jan 17, 2022 Issue: Medicare/Medicaid Health Issues
  • $80,000 Oct 17, 2021 Issue: Health Issues Medicare/Medicaid
  • $80,000 Jul 17, 2021 Issue: Medicare/Medicaid Health Issues
  • $80,000 Apr 19, 2021 Issue: Health Issues Medicare/Medicaid
  • $90,000 Jan 20, 2021 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $90,000 Oct 19, 2020 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $90,000 Jul 19, 2020 Issue: Health Issues Medicare/Medicaid
  • $90,000 Apr 19, 2020 Issue: Health Issues Medicare/Medicaid
  • $10,000 Oct 21, 2019 Issue: Health Issues
  • $20,000 Jul 17, 2019 Issue: Health Issues
  • $20,000 Apr 22, 2019 Issue: Health Issues

Former government officials who have lobbied for EYPT

7 former government officials from 6 congressional offices at 2 lobbying firms have lobbied for EYPT, most recently Jan 15, 2023.

  • Lucy McBath
    Michael Williams House New Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Brian Jones (2019); Legislative Correspondent, Sen. Brian Jones (2018-2019) Formerly with Lucy McBath · FORBES-TATE · Jan 15, 2023
  • Orrin G. Hatch
    Derrick White Senate New Deputy Communications Director, Sen. Orrin Hatch (2000-2001) Formerly with Orrin G. Hatch · FORBES-TATE · Jul 19, 2020
  • Allen Boyd
    Elizabeth Greer House New Chief of Staff, Rep. Allen Boyd (2001-2009) Formerly with Allen Boyd · FORBES-TATE · Feb 12, 2020
  • Max Baucus
    Jeffrey Forbes Senate New Staff Director, Senate Finance Committee (2003); Chief of Staff, Sen. Max Baucus (1999-2002) Formerly with Max Baucus · FORBES-TATE · Feb 12, 2020
  • Mike Crapo
    Barrett Thornhill Senate New Legislative Assistant, Sen. Mike Crapo (2003-2006); Legislative Assistant, Rep. Pat Toomey (2002-2003); Legislative Assistant, Rep. Charlie Norwood (2001-2002) Formerly with Mike Crapo · FORBES-TATE · Feb 12, 2020
  • Kathleen Mcauliffe House Counsel, House Democratic Leader Richard Gephardt 95-2000 Formerly Counsel, House Democratic Leader Richard Gephardt 95-2000 · HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) · Jan 21, 2020
  • Eric Cantor
    Aaron Cutler House Senior Policy Advisor, House Committee on National Resources; Senior Advisor for Policy and Outreach, Office of House Majority Leader Eric Cantor; Deputy Policy Director, House Committee on Energy and Commerce Formerly with Eric Cantor · HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) · Jan 21, 2020

EYPT Estimated quarterly lobbying spending

EYPT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
EYPT Income Statement
EYPT Balance Sheet
EYPT Cash Flow
U.S. Patents

New EYPT patent grants

  • Patent Title: Bioerodible ocular drug delivery insert and therapeutic method Feb. 17, 2026
  • Patent Title: Methods of treating acute respiratory distress syndrome with activators of tie-2 Feb. 10, 2026
  • Patent Title: Bioerodible drug delivery devices Jan. 06, 2026
  • Patent Title: Ocular injector Dec. 16, 2025
  • Patent Title: Bioerodible drug delivery devices Jun. 17, 2025
  • Patent Title: Small molecule activators of tie-2 Jan. 07, 2025
  • Patent Title: Methods of treating intraocular pressure with activators of tie-2 Dec. 24, 2024
  • Patent Title: Compositions, formulations and methods for treating ocular diseases Nov. 26, 2024
  • Patent Title: Method of treating an ocular condition by administering a humanized monoclonal antibodies that target ve-ptp (hptp-beta) Nov. 19, 2024
  • Patent Title: Ocular injector Sep. 24, 2024
  • Patent Title: Tie-2 activators targeting the schlemm's canal Aug. 20, 2024
  • Patent Title: Methods for treating vascular leak syndrome and cancer Jul. 23, 2024
  • Patent Title: Method of treating ocular conditions by administering an antibody that activates tie2 and binds vegf Jan. 16, 2024
  • Patent Title: Methods of treating intraocular pressure with activators of tie-2 Jun. 06, 2023
  • Patent Title: Small molecule activators of tie-2 Mar. 28, 2023
  • Patent Title: Formulations of tie-2 activators and methods of use thereof Aug. 16, 2022
  • Patent Title: Bioerodible drug delivery devices Apr. 12, 2022
  • Patent Title: Tie-2 activators targeting the schlemm's canal Feb. 22, 2022
  • Patent Title: Humanized monoclonal antibodies that target ve-ptp (hptp-beta) Nov. 23, 2021
  • Patent Title: Bioerodible silicon-based devices for delivery of therapeutic agents Jun. 08, 2021
  • Patent Title: Injector apparatus Jul. 30, 2019
  • Patent Title: Ocular inserter Jun. 18, 2019
  • Patent Title: Bioerodible sustained release drug delivery systems May. 28, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to EYPT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
EYPT News

Recent insights relating to EYPT

CNBC Recommendations

Recent picks made for EYPT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EYPT

EYPT Analyst Ratings

EYPT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
EYPT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $EYPT stock a Buy, Sell, or Hold?

  • What is the price target for $EYPT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

EYPT Top Shareholders
Shareholder
Shares Held
EYPT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $EYPT stock?

  • Who owns the most shares of $EYPT stock?

  • What funds own $EYPT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

EYPT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view EYPT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About EYPT

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

  • Address Watertown, MA
  • Market Cap 320.7 million
  • Employees 214
  • Industrial Classification Laboratory Analytical Instruments

EyePoint, Inc. Common Stock (EYPT) Historical Stock Prices

EyePoint, Inc. Common Stock (EYPT) closed at $3.72 on September 23, 2026. Over the past year its adjusted close ranged from $3.45 to $18.85. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month-23.61%
  • 3 months-74.17%
  • Year to date-79.64%
  • 1 year-72.22%
  • 3 years-55.98%
  • 5 years-68.26%
  • Max-4.86%
See every congressional and insider trade on the EYPT price chart

Quiver Premium charts EYPT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 4.10 4.18 3.71 3.72 3.72 2,022,398
Sep 22, 2026 4.08 4.21 3.97 4.07 4.07 4,463,692
Sep 21, 2026 3.87 4.10 3.80 4.02 4.02 3,861,464
Sep 18, 2026 3.95 4.06 3.77 3.85 3.85 7,266,552
Sep 17, 2026 3.57 4.01 3.50 3.99 3.99 6,975,498
Sep 16, 2026 3.66 3.74 3.42 3.45 3.45 4,965,305
Sep 15, 2026 4.27 4.27 3.63 3.66 3.66 3,894,199
Sep 14, 2026 4.30 4.34 4.16 4.25 4.25 2,531,741
Sep 11, 2026 4.32 4.43 4.17 4.23 4.23 2,728,042
Sep 10, 2026 4.32 4.40 4.10 4.25 4.25 4,317,047
Sep 9, 2026 4.50 4.56 4.28 4.34 4.34 2,984,523
Sep 8, 2026 4.58 4.69 4.47 4.56 4.56 2,271,836
Sep 4, 2026 4.53 4.69 4.49 4.58 4.58 1,901,886
Sep 3, 2026 4.74 4.92 4.46 4.57 4.57 2,625,997
Sep 2, 2026 4.36 4.81 4.33 4.79 4.79 4,716,139
Sep 1, 2026 4.40 4.61 4.35 4.58 4.58 3,261,201
Aug 31, 2026 4.44 4.58 4.37 4.50 4.50 3,506,365
Aug 28, 2026 4.59 4.67 4.36 4.48 4.48 4,393,543
Aug 27, 2026 4.93 4.99 4.50 4.63 4.63 5,999,646
Aug 26, 2026 5.03 5.07 4.93 4.99 4.99 3,261,916
Aug 25, 2026 4.98 5.29 4.96 5.00 5.00 4,133,632
Aug 24, 2026 5.17 5.35 4.87 4.87 4.87 4,155,639
Aug 21, 2026 5.47 5.50 4.97 5.32 5.32 8,186,380
Aug 20, 2026 6.18 6.29 5.29 5.40 5.40 7,406,287
Aug 19, 2026 6.04 6.34 5.63 6.30 6.30 8,792,924
Aug 18, 2026 4.73 5.52 4.70 5.47 5.47 16,238,028
Aug 17, 2026 4.06 4.90 3.95 4.87 4.87 52,268,276
Aug 14, 2026 13.53 14.76 13.40 14.75 14.75 2,511,098
Aug 13, 2026 13.59 13.69 13.25 13.48 13.48 1,202,186
Aug 12, 2026 13.05 13.77 13.02 13.53 13.53 2,261,368
Aug 11, 2026 13.11 13.11 12.37 13.05 13.05 2,058,473
Aug 10, 2026 14.22 14.32 13.02 13.07 13.07 1,757,173
Aug 7, 2026 13.04 14.08 13.03 13.89 13.89 1,655,696
Aug 6, 2026 12.25 13.03 12.01 12.83 12.83 2,240,810
Aug 5, 2026 11.88 12.74 11.85 12.25 12.25 2,450,067
Aug 4, 2026 12.44 12.70 11.54 11.67 11.67 2,929,693
Aug 3, 2026 12.34 12.51 12.02 12.42 12.42 1,479,461
Jul 31, 2026 12.81 12.83 12.04 12.25 12.25 1,711,475
Jul 30, 2026 12.17 13.00 11.79 12.86 12.86 1,561,104
Jul 29, 2026 11.98 12.36 11.55 11.92 11.92 2,054,155
Jul 28, 2026 12.34 12.53 11.72 11.96 11.96 1,698,346
Jul 27, 2026 12.48 13.03 12.17 12.41 12.41 1,390,307
Jul 24, 2026 12.45 12.50 12.06 12.19 12.19 1,468,697
Jul 23, 2026 12.45 12.89 12.29 12.47 12.47 1,284,723
Jul 22, 2026 12.81 13.04 12.52 12.66 12.66 1,063,990
Jul 21, 2026 12.66 13.23 12.45 13.05 13.05 1,585,308
Jul 20, 2026 13.27 13.79 12.65 12.66 12.66 1,099,731
Jul 17, 2026 12.76 13.69 12.61 13.30 13.30 1,283,890
Jul 16, 2026 14.14 14.20 12.86 13.04 13.04 1,551,216
Jul 15, 2026 13.73 14.00 13.41 13.85 13.85 1,484,510
Jul 14, 2026 14.32 14.58 13.71 13.73 13.73 1,064,508
Jul 13, 2026 14.45 14.72 13.89 14.28 14.28 1,122,270
Jul 10, 2026 14.80 14.80 13.89 14.72 14.72 1,638,977
Jul 9, 2026 14.00 14.99 13.97 14.84 14.84 1,570,866
Jul 8, 2026 13.97 14.49 13.69 14.01 14.01 1,899,461
Jul 7, 2026 14.65 14.85 13.73 14.02 14.02 2,117,886
Jul 6, 2026 14.00 14.65 13.40 14.44 14.44 1,589,400
Jul 2, 2026 13.22 14.19 13.01 13.98 13.98 1,490,930
Jul 1, 2026 14.73 15.92 13.17 13.20 13.20 2,153,433
Jun 30, 2026 14.18 15.38 13.96 14.30 14.30 2,319,320
Jun 29, 2026 13.77 14.19 13.43 14.11 14.11 1,579,256
Jun 26, 2026 13.71 14.07 13.52 13.66 13.66 3,554,606
Jun 25, 2026 14.37 14.88 13.57 13.71 13.71 1,249,997
Jun 24, 2026 14.38 14.85 14.29 14.40 14.40 895,082
Jun 23, 2026 13.62 14.88 13.61 14.38 14.38 1,551,534
Jun 22, 2026 13.62 14.01 13.49 13.73 13.73 842,461
Jun 18, 2026 13.53 14.03 13.26 13.58 13.58 1,290,270
Jun 17, 2026 12.89 13.51 12.78 13.15 13.15 1,180,462
Jun 16, 2026 12.08 13.08 12.05 12.88 12.88 1,471,638
Jun 15, 2026 13.09 13.33 11.93 12.08 12.08 1,084,002
Jun 12, 2026 12.67 13.05 12.61 13.03 13.03 1,093,547
Jun 11, 2026 12.41 12.66 11.92 12.50 12.50 1,260,368
Jun 10, 2026 11.77 12.35 11.58 12.33 12.33 1,161,652
Jun 9, 2026 11.48 11.85 11.29 11.77 11.77 1,874,484
Jun 8, 2026 11.90 11.99 11.39 11.45 11.45 805,677
Jun 5, 2026 12.24 12.41 11.64 11.78 11.78 925,249
Jun 4, 2026 12.54 13.16 12.24 12.26 12.26 815,092
Jun 3, 2026 12.51 12.51 12.17 12.34 12.34 837,713
Jun 2, 2026 13.07 13.10 12.27 12.53 12.53 993,493
Jun 1, 2026 13.52 13.52 12.60 13.15 13.15 1,308,111
May 29, 2026 13.50 14.02 13.48 13.58 13.58 1,061,075
May 28, 2026 13.13 14.03 13.01 13.50 13.50 1,435,507
May 27, 2026 13.38 14.03 12.79 13.16 13.16 1,825,963
May 26, 2026 13.00 13.35 12.74 13.35 13.35 918,190
May 22, 2026 12.87 13.43 12.72 12.93 12.93 783,890
May 21, 2026 12.46 13.01 12.33 12.78 12.78 559,618
May 20, 2026 11.95 12.76 11.91 12.50 12.50 1,082,275
May 19, 2026 11.68 12.02 11.40 11.82 11.82 736,322
May 18, 2026 12.35 12.50 11.68 11.70 11.70 732,049
May 15, 2026 13.04 13.11 12.33 12.35 12.35 538,881
May 14, 2026 13.38 13.52 13.04 13.24 13.24 514,834
May 13, 2026 13.45 13.60 13.21 13.43 13.43 838,320
May 12, 2026 14.01 14.01 13.35 13.62 13.62 764,203
May 11, 2026 13.76 14.68 13.76 13.98 13.98 989,493
May 8, 2026 13.35 13.75 13.29 13.66 13.66 661,535
May 7, 2026 13.39 14.14 13.22 13.41 13.41 1,122,341
May 6, 2026 13.73 14.21 12.95 13.35 13.35 1,214,781
May 5, 2026 13.86 14.07 13.31 13.75 13.75 727,383
May 4, 2026 13.24 13.88 13.10 13.85 13.85 1,062,782
May 1, 2026 13.29 13.74 12.98 13.34 13.34 905,099
Apr 30, 2026 13.01 13.43 12.89 13.20 13.20 950,102
Apr 29, 2026 13.23 13.28 12.53 12.86 12.86 805,717
Apr 28, 2026 13.44 13.85 13.28 13.47 13.47 612,462
Apr 27, 2026 13.74 14.30 13.46 13.60 13.60 700,563
Apr 24, 2026 13.79 14.17 13.54 13.77 13.77 625,638
Apr 23, 2026 14.25 14.38 13.60 13.84 13.84 685,313
Apr 22, 2026 14.25 14.42 14.05 14.24 14.24 989,009
Apr 21, 2026 15.04 15.18 14.09 14.11 14.11 1,534,761
Apr 20, 2026 14.87 15.33 14.79 15.07 15.07 803,385
Apr 17, 2026 15.00 15.25 14.76 14.93 14.93 1,264,341
Apr 16, 2026 14.63 14.87 14.51 14.81 14.81 588,191
Apr 15, 2026 14.34 14.68 14.15 14.63 14.63 590,039
Apr 14, 2026 14.52 14.76 14.24 14.34 14.34 598,467
Apr 13, 2026 14.18 14.87 13.98 14.52 14.52 956,165
Apr 10, 2026 14.29 14.36 13.90 14.19 14.19 742,028
Apr 9, 2026 14.03 14.41 13.91 14.23 14.23 903,901
Apr 8, 2026 14.33 14.40 13.90 14.17 14.17 1,084,778
Apr 7, 2026 12.98 13.59 12.57 13.57 13.57 939,035
Apr 6, 2026 13.34 13.35 12.78 13.11 13.11 869,294
Apr 2, 2026 12.82 13.55 12.62 13.40 13.40 1,154,744
Apr 1, 2026 13.08 13.69 12.90 13.02 13.02 885,125
Mar 31, 2026 12.14 13.00 12.14 12.89 12.89 1,844,118
Mar 30, 2026 12.47 12.55 11.82 11.85 11.85 792,193
Mar 27, 2026 12.95 13.12 12.44 12.50 12.50 843,539
Mar 26, 2026 12.98 13.24 12.65 13.06 13.06 768,064
Mar 25, 2026 12.70 13.33 12.70 13.05 13.05 687,426
Mar 24, 2026 12.69 12.83 12.07 12.59 12.59 820,701
Mar 23, 2026 13.40 13.55 12.66 12.83 12.83 851,085
Mar 20, 2026 13.75 13.86 13.11 13.23 13.23 1,034,795
Mar 19, 2026 13.60 13.97 13.25 13.79 13.79 886,563
Mar 18, 2026 13.95 14.02 13.35 13.64 13.64 939,289
Mar 17, 2026 13.75 14.10 13.53 13.90 13.90 1,147,288
Mar 16, 2026 13.37 13.53 13.04 13.45 13.45 1,111,516
Mar 13, 2026 13.91 14.05 12.90 13.20 13.20 1,238,188
Mar 12, 2026 14.64 14.90 13.51 14.03 14.03 1,802,424
Mar 11, 2026 15.27 15.64 14.88 14.92 14.92 1,263,577
Mar 10, 2026 15.69 16.14 15.34 15.44 15.44 1,161,822
Mar 9, 2026 15.58 15.85 15.05 15.67 15.67 1,486,785
Mar 6, 2026 15.15 16.17 15.01 15.75 15.75 1,893,565
Mar 5, 2026 17.98 17.98 15.52 15.76 15.76 2,695,888
Mar 4, 2026 17.62 18.45 17.14 18.00 18.00 1,723,063
Mar 3, 2026 17.75 18.39 17.57 18.32 18.32 1,950,221
Mar 2, 2026 17.18 18.87 16.92 18.34 18.34 1,639,993
Feb 27, 2026 17.72 17.85 16.93 17.56 17.56 2,731,341
Feb 26, 2026 17.83 17.91 17.06 17.86 17.86 983,166
Feb 25, 2026 17.20 17.95 17.11 17.76 17.76 1,796,179
Feb 24, 2026 17.14 17.74 16.75 17.05 17.05 1,172,949
Feb 23, 2026 15.25 17.10 15.10 17.07 17.07 1,544,794
Feb 20, 2026 14.58 15.44 14.20 15.33 15.33 1,074,279
Feb 19, 2026 14.32 15.14 14.00 14.70 14.70 2,569,050
Feb 18, 2026 14.82 15.21 14.00 14.36 14.36 2,414,478
Feb 17, 2026 12.40 15.69 12.34 14.91 14.91 8,720,639
Feb 13, 2026 13.13 13.69 12.79 12.94 12.94 790,189
Feb 12, 2026 13.10 13.10 12.50 13.01 13.01 985,061
Feb 11, 2026 13.76 13.94 12.78 12.85 12.85 942,736
Feb 10, 2026 14.16 14.32 13.49 13.72 13.72 851,220
Feb 9, 2026 13.33 14.20 13.05 14.07 14.07 877,564
Feb 6, 2026 13.04 13.42 12.73 13.30 13.30 966,656
Feb 5, 2026 12.39 13.68 12.38 12.73 12.73 1,632,144
Feb 4, 2026 12.83 12.83 12.11 12.33 12.33 1,766,820
Feb 3, 2026 13.29 13.49 12.22 12.80 12.80 1,541,529
Feb 2, 2026 13.44 14.00 13.08 13.29 13.29 1,931,015
Jan 30, 2026 14.65 14.92 13.49 13.52 13.52 1,317,980
Jan 29, 2026 14.86 15.31 14.64 14.75 14.75 671,701
Jan 28, 2026 15.81 15.92 14.98 15.04 15.04 683,641
Jan 27, 2026 15.45 15.84 15.31 15.81 15.81 486,657
Jan 26, 2026 14.99 15.49 14.62 15.45 15.45 670,643
Jan 23, 2026 16.26 16.73 14.86 15.18 15.18 1,096,179
Jan 22, 2026 15.60 16.41 15.60 16.34 16.34 1,385,782
Jan 21, 2026 15.56 15.87 14.99 15.53 15.53 961,140
Jan 20, 2026 14.71 15.81 14.50 15.54 15.54 1,034,501
Jan 16, 2026 15.95 16.18 15.01 15.08 15.08 882,550
Jan 15, 2026 17.16 17.61 15.77 15.84 15.84 1,579,252
Jan 14, 2026 15.93 16.07 15.64 15.92 15.92 876,014
Jan 13, 2026 15.94 16.00 15.14 15.93 15.93 868,343
Jan 12, 2026 16.25 16.39 15.35 15.94 15.94 829,783
Jan 9, 2026 17.08 17.38 16.17 16.23 16.23 877,330
Jan 8, 2026 17.50 17.74 16.94 17.08 17.08 746,893
Jan 7, 2026 17.32 18.20 16.98 17.37 17.37 1,210,175
Jan 6, 2026 17.43 17.55 16.79 16.86 16.86 737,587
Jan 5, 2026 17.54 17.54 16.67 17.43 17.43 1,333,225
Jan 2, 2026 18.36 18.50 16.88 17.48 17.48 775,980
Dec 31, 2025 17.89 18.34 17.74 18.27 18.27 638,738
Dec 30, 2025 18.30 18.50 17.87 17.89 17.89 467,549
Dec 29, 2025 18.16 18.43 17.79 18.20 18.20 697,798
Dec 26, 2025 18.19 18.71 17.90 18.29 18.29 821,945
Dec 24, 2025 18.43 18.77 18.05 18.26 18.26 431,583
Dec 23, 2025 18.71 18.99 17.61 18.38 18.38 1,259,402
Dec 22, 2025 17.36 19.00 17.34 18.85 18.85 965,971
Dec 19, 2025 17.10 17.98 16.75 17.43 17.43 5,276,240
Dec 18, 2025 16.87 17.43 16.52 17.06 17.06 1,496,599
Dec 17, 2025 16.94 17.37 16.57 16.66 16.66 1,185,275
Dec 16, 2025 16.31 17.40 16.26 16.93 16.93 1,312,529
Dec 15, 2025 16.03 16.48 15.81 16.40 16.40 814,531
Dec 12, 2025 16.30 16.54 15.97 15.99 15.99 719,751
Dec 11, 2025 16.82 17.10 15.97 16.10 16.10 1,108,073
Dec 10, 2025 17.17 17.30 16.64 16.72 16.72 1,201,343
Dec 9, 2025 17.58 18.17 17.05 17.08 17.08 1,440,636
Dec 8, 2025 17.88 19.11 17.72 17.82 17.82 1,302,668
Dec 5, 2025 16.86 17.82 16.59 17.74 17.74 1,463,034
Dec 4, 2025 14.52 17.00 14.40 16.72 16.72 2,029,885
Dec 3, 2025 13.78 14.60 13.78 14.52 14.52 810,494
Dec 2, 2025 14.36 14.46 13.61 13.69 13.69 724,897
Dec 1, 2025 14.66 14.69 14.21 14.26 14.26 712,319
Nov 28, 2025 14.81 14.95 14.64 14.83 14.83 331,316
Nov 26, 2025 14.50 14.96 14.26 14.79 14.79 850,337
Nov 25, 2025 14.40 14.76 13.86 14.74 14.74 805,705
Nov 24, 2025 13.84 14.49 13.75 14.40 14.40 938,963
Nov 21, 2025 13.63 13.97 13.43 13.68 13.68 926,868
Nov 20, 2025 14.49 14.67 13.55 13.64 13.64 1,342,002
Nov 19, 2025 13.80 14.64 13.70 14.28 14.28 1,402,889
Nov 18, 2025 13.14 14.55 12.95 13.96 13.96 2,190,483
Nov 17, 2025 11.69 13.29 11.55 13.13 13.13 1,383,792
Nov 14, 2025 11.30 12.04 11.30 11.58 11.58 1,126,121
Nov 13, 2025 11.91 12.06 11.33 11.51 11.51 1,139,778
Nov 12, 2025 11.65 12.22 11.32 11.99 11.99 1,240,682
Nov 11, 2025 11.28 11.78 11.28 11.64 11.64 745,103
Nov 10, 2025 11.45 11.78 11.19 11.35 11.35 1,009,898
Nov 7, 2025 10.90 11.21 10.28 11.21 11.21 1,204,048
Nov 6, 2025 10.92 12.00 10.86 11.08 11.08 1,210,180
Nov 5, 2025 11.30 12.14 9.65 11.02 11.02 4,600,697
Nov 4, 2025 12.13 12.95 11.96 12.39 12.39 1,514,236
Nov 3, 2025 13.13 13.34 12.22 12.45 12.45 1,150,493
Oct 31, 2025 12.20 13.12 11.92 13.09 13.09 1,514,350
Oct 30, 2025 11.55 12.25 11.55 12.21 12.21 1,532,096
Oct 29, 2025 12.46 12.47 11.62 11.73 11.73 1,352,092
Oct 28, 2025 12.06 12.37 11.91 12.25 12.25 702,980
Oct 27, 2025 12.00 12.37 11.88 12.11 12.11 836,420
Oct 24, 2025 11.73 11.99 11.52 11.98 11.98 1,121,709
Oct 23, 2025 11.57 11.57 11.15 11.50 11.50 1,255,055
Oct 22, 2025 11.90 12.08 11.31 11.45 11.45 1,528,468
Oct 21, 2025 12.04 12.21 11.77 11.81 11.81 1,161,146
Oct 20, 2025 11.75 12.04 11.20 12.03 12.03 1,406,357
Oct 17, 2025 11.40 11.65 11.18 11.63 11.63 1,387,330
Oct 16, 2025 11.80 12.31 11.45 11.55 11.55 1,976,984
Oct 15, 2025 13.12 13.49 11.25 11.73 11.73 5,785,451
Oct 14, 2025 13.11 13.41 12.86 13.16 13.16 531,143
Oct 13, 2025 13.60 13.76 13.06 13.34 13.34 720,832
Oct 10, 2025 13.98 14.11 13.50 13.57 13.57 659,580
Oct 9, 2025 13.80 14.36 13.63 13.97 13.97 1,779,627
Oct 8, 2025 13.33 14.28 13.01 13.88 13.88 1,591,161
Oct 7, 2025 13.66 14.08 12.99 13.25 13.25 1,132,646
Oct 6, 2025 13.95 13.95 13.38 13.62 13.62 754,946
Oct 3, 2025 13.65 14.04 13.48 13.73 13.73 1,111,527
Oct 2, 2025 12.92 13.75 12.54 13.50 13.50 1,195,381
Oct 1, 2025 14.34 14.57 12.81 12.91 12.91 1,517,715
Sep 30, 2025 14.02 14.91 13.66 14.24 14.24 2,396,086
Sep 29, 2025 13.86 14.13 13.41 14.05 14.05 759,692
Sep 26, 2025 13.25 14.10 13.07 13.90 13.90 822,983
Sep 25, 2025 13.93 14.06 13.13 13.19 13.19 599,714
Sep 24, 2025 13.43 14.38 13.29 14.08 14.08 992,466
Sep 23, 2025 13.30 13.52 13.18 13.39 13.39 497,053

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
EyePoint, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at EYPT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation